Navigation Links
DyCE(TM) (Dynamic Contrast Enhancement) Technology Now Part of CRi's Analysis Software Suite for the Popular Maestro(TM) in vivo Molecular Imaging System
Date:3/20/2008

WOBURN, Mass., March 20 /PRNewswire/ -- Cambridge Research & Instrumentation, Inc. (CRi) is shipping DyCE(TM) (Dynamic Contrast Enhancement), a new technology application, to users of the award-winning Maestro(TM) in vivo molecular imaging system. Customers can now generate all- optical anatomical images of mouse models in only a few minutes, saving time and enabling better time-resolved images of molecular probe distribution.

CRi has an exclusive commercialization agreement with Massachusetts General Hospital (MGH) for its DyCE application which received widespread acclaim when introduced at the recent Society of Molecular Imaging/Academy of Molecular Imaging joint conference for in vivo imaging. DyCE was also featured in the cover article in Nature Photonics in August of 2007.

"DyCE is a quantum leap forward for optical imaging, poised to revolutionize in vivo fluorescence imaging," says James Mansfield, Director of Multispectral Imaging Systems at CRi. "Our customers can now produce anatomical images in record time and also save significant money versus conventional means."

Anatomical images are produced using DyCE in the following way. A bolus of an inert near-infrared dye (such as indocyanine green) is injected, and then a time-based series of data is collected. Using CRi's analysis software, this data set is interpreted to delineate most of the major organ systems, using optical imaging alone. This organ-specific imaging is possible, because organs have characteristic uptake or distribution patterns over time that can be 'illuminated' by the dye passing through, distinguishing them from other structures.

These in vivo anatomical maps can be overlaid co-registered with simultaneously acquired images of a targeted molecular probe to delineate the marker's specific anatomical and physical location at any time point in the study.

"CRi is uniquely positioned to commercialize DyCE capitalizing on the combination of our advanced multispectral in vivo imaging systems and our industry-leading data analysis tools," explains George Abe, CRi's President and CEO.

"We are pleased to partner with the Massachusetts General Hospital in this endeavor and are excited to enable our customers to further advance their small animal imaging capabilities", continued Abe.

CRi will be exhibiting the latest automated Maestro 2 system featuring DyCE along with CRi's cellular imaging solutions at the Annual Meeting of the American Association for Cancer Research (AACR), April 12 to 16 (Booth 235). Attendees can make an appointment to meet with a sales or technical representative by e-mailing aacr@cri-inc.com or calling (Toll-Free US) 1-800- 383-7924.

CRi is a Boston-based biomedical imaging company providing innovative optical imaging solutions to our customers for more than 20 years. Our multidisciplinary team is dedicated to working with our academic and commercial customers to provide high-value solutions. We provide comprehensive imaging and analysis solutions that enable the user to investigate and characterize biological phenotypes while preserving spatial context. CRi's innovative solutions encompass sub-cellular, cellular and whole animal applications, and are being utilized around the world to enable breakthroughs in research, health and medicine.

For more information visit our website at http://www.cri-inc.com or contact:

Ross Nakatsuji

CRi Marketing/Sales Group Leader

35-B Cabot Road, Woburn, MA 01801 USA

(P) 1-781-935-9099, extension 177

(C) 1-781-405-4000

(E) rnakatsuji@cri-inc.com


'/>"/>
SOURCE Cambridge Research & Instrumentation, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Parker Waichman Alonso LLP Files Suit Against General Electric Company on Behalf of a Man Who Developed Nephrogenic Systemic Fibrosis (NSF) from Contrast Agent Omniscan
2. Allergic reactions to gadolinium-based contrast agents are rare, study finds
3. Bayer HealthCare Pharmaceuticals and MedAssets Supply Chain Systems Sign a Three-Year Agreement for Magnevist(R) Magnetic Resonance Contrast Media
4. Stem Cell Technology Offers Promise of Huge Savings for Drug Developers
5. Genetic Engineering & Biotechnology News reports on clinical trials in developing countries
6. New England Technology Foundation Announces Connecting for Childrens Charities 2008 Event
7. Healthcare Tech and the World: Personalized Technology to Benefit Healthcare Consumers in the Future
8. RIVAs Cutting Edge Technology To Help Intermountain Healthcare Enhance Medication Delivery Safety
9. New Technology No Better at Spotting Anesthesia Awareness
10. Virtual reality and computer technology improve stroke rehabilitation
11. Advanced Technology in Dental Imaging Benefits Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... , ... October 13, 2017 , ... ... and Agile Software Development, has been awarded a contract by the Center for ... Agreement (BPA) aims to accelerate the enterprise use of Agile methodologies in a ...
(Date:10/12/2017)... San Francisco, CA (PRWEB) , ... October 12, ... ... and Dr. Cheng, are now treating sleep apnea using cutting-edge Oventus ... sleep apnea, a serious sleep disorder characterized by frequent cessation in breathing. Oral ...
(Date:10/12/2017)... ... ... The American College of Medical Informatics (ACMI) will present the 2017 Morris F. ... AMIA’s Annual Symposium in Washington, D.C. AMIA’s Annual Symposium is taking place ... the field of medical informatics, this prestigious award is presented to an individual whose ...
(Date:10/12/2017)... ... October 12, 2017 , ... HMP , a ... of a 2017 Folio Magazine Eddie Digital Award for ‘Best B-to-B Healthcare Website.’ Winners ... October 11, 2017. , The annual award competition recognizes editorial and design excellence across ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... first interactive health literacy software tool, and the Cancer Patient Education Network (CPEN), ... patient education, today announce a new strategic alliance. , As CPEN’s strategic ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... INDIANAPOLIS , Oct. 2, 2017  Eli Lilly ... its financial results for the third quarter of 2017 ... a conference call on that day with the investment ... performance. The conference call will begin at ... public can access a live webcast of the conference ...
(Date:10/2/2017)... , Oct. 2, 2017 Halo Labs announces the ... analysis system called the HORIZON at MIBio 2017 in ... subvisible and visible particulate matter in biopharmaceutical samples with unprecedented speed ... of the novel technique Backgrounded Membrane Imaging. ... The HORIZON subvisible particle analysis system ...
(Date:9/28/2017)... -- Hill-Rom Holdings, Inc. (NYSE: HRC), will host its ... on Friday, November 3, 2017, beginning at 7:00 a.m. ... 8:30 a.m. (CDT) / 9:30 a.m. (EDT). ... and guidance for 2018, Hill-Rom executives will also highlight ... and long-range financial outlook through 2020. ...
Breaking Medicine Technology: